Nitazoxanide 200mg Tablet Franchise in Ahmedabad

Antiprotozoal & Anthelmintic Tablet Supplier in Mumbai

Nitanap 200 Tablet Distributor in Delhi

Intestinal Parasitic Infection Tablet Franchise Opportunity in Bangalore

Diarrheal Disease Treatment Tablet Stockist in Hyderabad
Nitazoxanide Export & Manufacturing in Chandigarh

Home/Products /nitazoxanide-200mg-tablet

Nitanap 200 Tablet

Composition : Nitazoxanide (200mg) Tablet

Dosage Form : Tablet

Packaging Type : Blister

Packaging : 10*10

Price : ₹1/-

Nitanap 200 Tablet contains Nitazoxanide 200mg, a broad-spectrum antiprotozoal and anthelmintic medicine used for the treatment of intestinal parasitic infections and infectious diarrhea. It is effective against a wide range of protozoa and helminths affecting the gastrointestinal tract.

Nitazoxanide works by interfering with anaerobic energy metabolism in parasites, leading to inhibition of growth and elimination of infection. Its dual activity makes it a preferred choice in mixed parasitic and protozoal gastrointestinal conditions.

For distributors and healthcare suppliers, Nitanap 200 Tablet is a high-demand gastrointestinal anti-infective, commonly prescribed by pediatricians, gastroenterologists, and general physicians. Seasonal outbreaks and endemic parasitic infections ensure steady market requirement.

Adding Nitanap 200 Tablet to your gastrointestinal and anti-infective therapy segment creates strong opportunities in retail pharmacies, hospitals, clinics, export markets, and third-party manufacturing. Its proven efficacy, broad-spectrum action, and strong prescriber trust make it a valuable product in pharmaceutical distribution portfolios.

Read More

About the Product

Nitanap 200 Tablet contains Nitazoxanide 200mg, a broad-spectrum antiprotozoal and anthelmintic medicine used for the treatment of intestinal parasitic infections and infectious diarrhea. It is effective against a wide range of protozoa and helminths affecting the gastrointestinal tract.

Nitazoxanide works by interfering with anaerobic energy metabolism in parasites, leading to inhibition of growth and elimination of infection. Its dual activity makes it a preferred choice in mixed parasitic and protozoal gastrointestinal conditions.

For distributors and healthcare suppliers, Nitanap 200 Tablet is a high-demand gastrointestinal anti-infective, commonly prescribed by pediatricians, gastroenterologists, and general physicians. Seasonal outbreaks and endemic parasitic infections ensure steady market requirement.

Adding Nitanap 200 Tablet to your gastrointestinal and anti-infective therapy segment creates strong opportunities in retail pharmacies, hospitals, clinics, export markets, and third-party manufacturing. Its proven efficacy, broad-spectrum action, and strong prescriber trust make it a valuable product in pharmaceutical distribution portfolios.

Some patients may experience mild gastrointestinal discomfort, nausea, vomiting, abdominal pain, or headache. Rarely, allergic reactions, dizziness, or skin rashes may occur and require discontinuation and medical attention.

Nitazoxanide 200mg Tablet is indicated for the treatment of infections caused by protozoa and helminths, including giardiasis, amoebiasis, and certain viral gastroenteritis. It helps eliminate the causative pathogens, relieve digestive disturbances, and prevent further complications related to parasitic or viral intestinal infections.

This medicine should be used under medical supervision. Patients with liver or kidney impairment, or those taking other medications, should consult their healthcare provider before use. Complete the prescribed course to ensure effective treatment.

Store in a cool, dry place below 25°C, away from direct sunlight and moisture. Keep the tablets in their original packaging and out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation